FRANKFURT (dpa-AFX) – The Dax (DAX 40) is probably continuing its stabilization in the middle of the week: An hour before the start of trading, the X-Dax (DAX 40) signaled an increase of 0.5 percent to 15 as an over-the-counter indicator for the leading German index 922 points. The euro zone-The leading index EuroStoxx 50 (EURO STOXX 50) is expected to be similarly strong.
For the Dax, it is initially a return to the 50-day line at currently 15,961 points, before the hurdle at 16,000 points comes into focus again.
Support came from Wall Street, where the rally was solidified after the European close. Technology stocks in particular were in demand again after the recent correction. In Asia, the Japanese stock exchange in particular took up this template. In China, meanwhile, investors clawed back some of the previous day’s gains after weak data on industrial earnings. Reports of possible further US restrictions on exports of high-performance chips to China also had a negative impact.
An approval for the eye medicine Eylea from the US biotech group Regeneron (Regeneron Pharmaceuticals), which was initially rejected by the US drug agency FDA, weighed on Bayer’s share price. Bayer has the marketing rights to the drug. Before trading, Tradegate was down 1.3 percent at the Xetra close.
The semiconductor manufacturer Elmos (Elmos Semiconductor) wants to sell the production of starting material for the Chi production (wafers) in Dortmund to the US group Littelfuse. The purchase price amounts to around 93 million euros, the SDAX-listed company announced. Pre-market on Tradegate, the shares rose by 1.1 percent compared to the Xetra close.
Siemens Energy (Siemens Energy) continued its recent stabilization with a premarket gain on Tradegate of 4.3 percent. On Friday they had collapsed by more than 37 percent according to withdrawn forecasts./ajx/jha/